Published in Cogn Behav Neurol on September 01, 2007
Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders. Br J Clin Pharmacol (2015) 0.97
Development of the Huntington disease family concerns and strategies survey from focus group data. J Nurs Meas (2010) 0.92
Early onset familial Alzheimer Disease with spastic paraparesis, dysarthria, and seizures and N135S mutation in PSEN1. Alzheimer Dis Assoc Disord (2008) 0.88
Cognitive and noncognitive neurological features of young-onset dementia. Dement Geriatr Cogn Disord (2009) 0.84
FoxO proteins in the nervous system. Anal Cell Pathol (Amst) (2015) 0.83
Clinical genetics of Alzheimer's disease. Biomed Res Int (2014) 0.82
A novel p.Leu(381)Phe mutation in presenilin 1 is associated with very early onset and unusually fast progressing dementia as well as lysosomal inclusions typically seen in Kufs disease. J Alzheimers Dis (2014) 0.82
Taking aim at Alzheimer's disease through the mammalian target of rapamycin. Ann Med (2014) 0.82
Clinical and molecular studies reveal a PSEN1 mutation (L153V) in a Peruvian family with early-onset Alzheimer's disease. Neurosci Lett (2014) 0.80
New genes and new insights from old genes: update on Alzheimer disease. Continuum (Minneap Minn) (2013) 0.80
Regeneration in the nervous system with erythropoietin. Front Biosci (Landmark Ed) (2016) 0.76
Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med (2012) 14.14
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol (2015) 5.10
Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol (2009) 4.73
Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol (2008) 4.73
Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep (2006) 4.06
TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J Neuropathol Exp Neurol (2007) 2.97
Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis. Neurology (2013) 2.94
Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci (2002) 2.80
Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet (2011) 2.76
Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative. Lancet Neurol (2007) 2.72
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA (2013) 2.58
Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J Neuropathol Exp Neurol (2006) 2.43
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol (2013) 2.32
Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production. Proc Natl Acad Sci U S A (2002) 2.29
Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci U S A (2013) 2.27
Granular cell tumor: immunohistochemical assessment of inhibin-alpha, protein gene product 9.5, S100 protein, CD68, and Ki-67 proliferative index with clinical correlation. Arch Pathol Lab Med (2004) 2.24
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Accumulation of prion protein in the brain that is not associated with transmissible disease. Proc Natl Acad Sci U S A (2007) 2.06
Association between conformational mutations in neuroserpin and onset and severity of dementia. Lancet (2002) 2.02
Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet (2011) 2.02
VZV multifocal vasculopathy with ischemic optic neuropathy, acute retinal necrosis and temporal artery infection in the absence of zoster rash. J Neurol Sci (2013) 2.00
TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov Disord (2009) 1.95
Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clin Investig (Lond) (2012) 1.90
Varicella zoster virus in the temporal artery of a patient with giant cell arteritis. J Neurol Sci (2013) 1.83
Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease. Arch Neurol (2004) 1.78
Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition. Arch Pathol Lab Med (2008) 1.61
Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology. Proc Natl Acad Sci U S A (2007) 1.60
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 1.58
Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders. J Neurosci (2006) 1.57
Chitin-like polysaccharides in Alzheimer's disease brains. Curr Alzheimer Res (2005) 1.51
The value of quantitative electroencephalography in clinical psychiatry: a report by the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (2006) 1.51
Hippocampus volume loss due to chronic heavy drinking. Alcohol Clin Exp Res (2006) 1.51
Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J Biol Chem (2004) 1.50
Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques. Biochemistry (2005) 1.47
Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J Biol Chem (2003) 1.47
Hereditary diffuse leukoencephalopathy with spheroids: clinical, pathologic and genetic studies of a new kindred. Acta Neuropathol (2006) 1.47
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet (2012) 1.46
Dural lesions mimicking meningiomas. Hum Pathol (2002) 1.45
Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Sci Transl Med (2014) 1.45
Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with α-synuclein. Acta Neuropathol (2015) 1.42
Variable phenotype in a P102L Gerstmann-Sträussler-Scheinker Italian family. Can J Neurol Sci (2003) 1.40
Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease. J Biol Chem (2008) 1.40
Corticobasal syndrome associated with the A9D Progranulin mutation. J Neuropathol Exp Neurol (2007) 1.39
Forensic applications of cerebral single photon emission computed tomography in mild traumatic brain injury. J Am Acad Psychiatry Law (2008) 1.39
White matter abnormalities and working memory impairment in systemic lupus erythematosus. Cogn Behav Neurol (2013) 1.39
SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. Brain (2010) 1.38
Amnesia and crime: a neuropsychiatric response. J Am Acad Psychiatry Law (2008) 1.38
Molecular distinction between pathogenic and infectious properties of the prion protein. J Virol (2003) 1.38
APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians. Ann Neurol (2006) 1.36
Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol (2009) 1.32
Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy. Am J Pathol (2007) 1.32
The A431E mutation in PSEN1 causing familial Alzheimer's disease originating in Jalisco State, Mexico: an additional fifteen families. Neurogenetics (2006) 1.31
Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice. J Neurosci (2008) 1.30
Informatics training in pathology residency programs: proposed learning objectives and skill sets for the new millennium. Arch Pathol Lab Med (2003) 1.27
Neuropsychiatric complications of traumatic brain injury: a critical review of the literature (a report by the ANPA Committee on Research). J Neuropsychiatry Clin Neurosci (2007) 1.26
Protocol for the examination of specimens from patients with tumors of the brain/spinal cord. Arch Pathol Lab Med (2008) 1.25
Frontotemporal dementia: implications for understanding Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.23
Characteristics of frontotemporal dementia patients with a Progranulin mutation. Ann Neurol (2006) 1.22
Hypercortisolism in alcohol dependence and its relation to hippocampal volume loss. J Stud Alcohol (2006) 1.21
White matter tauopathy with globular glial inclusions: a distinct sporadic frontotemporal lobar degeneration. J Neuropathol Exp Neurol (2008) 1.21
Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment. Neuropsychiatr Dis Treat (2005) 1.20
Initial evaluations for multiple sclerosis in a university multiple sclerosis center: outcomes and role of magnetic resonance imaging in referral. Arch Neurol (2005) 1.18
Bax deletion prevents neuronal loss but not neurological symptoms in a transgenic model of inherited prion disease. Proc Natl Acad Sci U S A (2004) 1.18
The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family. Brain (2007) 1.18
Selenium level and cognitive function in rural elderly Chinese. Am J Epidemiol (2007) 1.18
MRI characteristics and scoring in HDLS due to CSF1R gene mutations. Neurology (2012) 1.17
Apolipoprotein E and mortality in African-Americans and Yoruba. J Alzheimers Dis (2003) 1.16
Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature. Neuropsychiatr Dis Treat (2008) 1.14
Abnormal iron metabolism and oxidative stress in mice expressing a mutant form of the ferritin light polypeptide gene. J Neurochem (2009) 1.14
Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype. Ann Neurol (2011) 1.13
Depression and cognitive complaints following mild traumatic brain injury. Am J Psychiatry (2009) 1.12
Defining and diagnosing involuntary emotional expression disorder. CNS Spectr (2006) 1.12
Predictors of cognitive decline following coronary artery bypass graft surgery. Ann Thorac Surg (2004) 1.11
Cerebral amyloid angiopathy and parenchymal amyloid deposition in transgenic mice expressing the Danish mutant form of human BRI2. Brain Pathol (2008) 1.10
Caspase-6 activation in familial alzheimer disease brains carrying amyloid precursor protein or presenilin i or presenilin II mutations. J Neuropathol Exp Neurol (2009) 1.09
Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation. Brain (2004) 1.09
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol (2014) 1.08
Constraint-induced movement therapy after stroke: efficacy for patients with minimal upper-extremity motor ability. Arch Phys Med Rehabil (2005) 1.08
Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype. Arch Neurol (2007) 1.07
Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein. J Neurosci (2005) 1.07
Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities. J Neurosci (2008) 1.07
Neurodegeneration caused by proteins with an aberrant carboxyl-terminus. J Neuropathol Exp Neurol (2004) 1.06
Cognition, MRS neurometabolites, and MRI volumetrics in non-neuropsychiatric systemic lupus erythematosus: preliminary data. Cogn Behav Neurol (2005) 1.06
Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel. PLoS One (2013) 1.06
Abeta42 gene vaccination reduces brain amyloid plaque burden in transgenic mice. J Neurol Sci (2006) 1.05
Screening for C9ORF72 repeat expansion in FTLD. Neurobiol Aging (2012) 1.05
Late life leisure activities and risk of cognitive decline. J Gerontol A Biol Sci Med Sci (2012) 1.04
Human prion disease and relative risk associated with chronic wasting disease. Emerg Infect Dis (2006) 1.02
Hypothyroid myopathy with a strikingly elevated serum creatine kinase level. Muscle Nerve (2002) 1.02